Related Experiment Videos
Current knowledge of mechanisms of carcinogenicity: genotoxins versus non-genotoxins
1ZENECA Central Toxicology Laboratory, Macclesfield, Cheshire, UK.
Human & Experimental Toxicology
|January 1, 1994
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Strategic considerations in industry's use of in vitro toxicology.
Toxicology in vitro : an international journal published in association with BIBRA·2010
Prospects for reduction and replacement alternatives in regulatory toxicology.
Toxicology in vitro : an international journal published in association with BIBRA·2010
Scientific analysis of the proposed uses of the T25 dose descriptor in chemical carcinogen regulation.
Archives of toxicology·2002
The impact of the introduction of the ethical review process for research using animals in the UK: attitudes to alternatives among those working With experimental animals.
Alternatives to laboratory animals : ATLA·2001
Ethical review of regulatory toxicology guidelines involving experiments on animals: the example of endocrine disrupters.
Toxicological sciences : an official journal of the Society of Toxicology·2000
Judgments of chemical risks: comparisons among senior managers, toxicologists, and the public.
Risk analysis : an official publication of the Society for Risk Analysis·1998
Establishment of a rat model of bronchopulmonary dysplasia complicated with pulmonary hypertension and its potential applications.
Human & experimental toxicology·2026
Pulmonary iron oxide (Fe3O4) nanoparticle-biomolecule interactions modified during aging and metabolic syndrome disease progression.
Human & experimental toxicology·2026
Stevioside inhibits colorectal cancer progression by regulating macrophage polarization.
Human & experimental toxicology·2026
Predictive factors of severe outcome in glufosinate ammonium poisoning: A retrospective study in Vietnam.
Human & experimental toxicology·2025
Usnic Acid induces dual-pathway apoptosis in SKOV-3 ovarian cancer cells via PARP1 inhibition and MAPK pathway activation.
Human & experimental toxicology·2025